Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Liver biopsy would be done by Endoscopic Ultrasound using Acquire needle.
In this study, we aim to evaluate the tissue adequacy of EUS guided liver biopsy for parenchymal liver disease and to evaluate if diagnostic yield of left lobe is non-inferior to right lobe biopsies and to assess if combination biopsies have better yield than single lobe biopsies. Safety of the procedure and technical success would be noted.
The data would be analysed using SPSS software and needful variables and tests would be used as per statistical requirement.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Endoscopic USG guided Liver biopsy | Experimental | Olympus linear echo endoscope (GF -UCT 180, Olympus Ltde, Tkyo, Japan) will be used. 19 Gz EUS Acquire needle Boston ©Scientific Corp will be used for liver tissue acquisition. |
|
| Percutaneous Liver biopsy | Active Comparator | All liver biopsies done in the Institute as routine procedure by percutaneous route would be compared with the EUS guided biopsy in respect to safety , tissue quality and diagnostic yield . |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Endoscopic USG guided Liver biopsy | Device | Diagnostic yield with EUS guided liver biopsy - Left lobe Bx vs combined right and left lobe or vs right lobe would be assessed. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Diagnostic yield with EUS guided liver biopsy . | The diagnostic yield of a right lobe biopsy and left lobe biopsy would be compared to see if right lobe biopsy gives any additional information for diagnosis when compared to left lobe . | 3 days |
| Measure | Description | Time Frame |
|---|---|---|
| Safety of procedure | Sedation related adverse effect will be monitored as per the institute protocol . Any type of bleed during procedure or needing additional intervention would be recorded as a major adverse effect . | 3 days |
| Duration of procedure |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Asian Institute of Gastroenterology Hospitals | Hyderabad | Telangana | 500089 | India |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 23916397 | Background | Gor N, Salem SB, Jakate S, Patel R, Shah N, Patil A. Histological adequacy of EUS-guided liver biopsy when using a 19-gauge non-Tru-Cut FNA needle. Gastrointest Endosc. 2014 Jan;79(1):170-2. doi: 10.1016/j.gie.2013.06.031. Epub 2013 Jul 31. No abstract available. | |
| 19231495 | Background | Dewitt J, McGreevy K, Cummings O, Sherman S, Leblanc JK, McHenry L, Al-Haddad M, Chalasani N. Initial experience with EUS-guided Tru-cut biopsy of benign liver disease. Gastrointest Endosc. 2009 Mar;69(3 Pt 1):535-42. doi: 10.1016/j.gie.2008.09.056. |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D065626 | Non-alcoholic Fatty Liver Disease |
| D006519 | Hepatitis, Alcoholic |
| ID | Term |
|---|---|
| D005234 | Fatty Liver |
| D008107 | Liver Diseases |
| D004066 | Digestive System Diseases |
| D006505 | Hepatitis |
Not provided
Not provided
All liver biopsies done in the Institute as routine procedure by percutaneous route would be compared with the EUS guided biopsy in respect to safety , tissue quality and diagnostic yield.
Not provided
Not provided
The biopsy specimens would be reported independently by two pathologists who would be masked to the source of tissue ( right/ left lobe ).
| Percutaneous Liver Biopsy | Device | All liver biopsies done in the Institute as routine procedure by percutaneous route would be compared with the EUS guided biopsy in respect to safety , tissue quality and diagnostic yield . |
|
Time between start and end of the procedure would be noted .
| 30 minutes |
| Size of tissue acquired | The length of the biopsy tissue would be ascertained immediately by onsite pathologist and would be assessed as per the AASLD and Royal College of Pathology definition . | 3 days |
| Number of portal tracts | The adequacy of the sample would be assessed as per the AASLD and Royal College of Pathology definition (CPTs 11) . | 3 days |
| Post procedural complications | Any procedure related complications such as pain (>6 on VAS) and bleeding would be noted . | 3 days |
| NAS score in fatty liver patients | Difference in NAS score between right lobe and right vs left lobe in fatty liver patients | 3 days |
| Patient recovery time | Patient recovery time when compared to per cutaneous liver biopsy procedure . | 3 days |
| 27530070 | Background | Schulman AR, Thompson CC, Odze R, Chan WW, Ryou M. Optimizing EUS-guided liver biopsy sampling: comprehensive assessment of needle types and tissue acquisition techniques. Gastrointest Endosc. 2017 Feb;85(2):419-426. doi: 10.1016/j.gie.2016.07.065. Epub 2016 Aug 13. |
| D008108 |
| Liver Diseases, Alcoholic |
| D020751 | Alcohol-Induced Disorders |
| D019973 | Alcohol-Related Disorders |
| D019966 | Substance-Related Disorders |
| D064419 | Chemically-Induced Disorders |